Topotecan and paclitaxel were evaluated in a randomized, multicenter study of patients with advanced epithelial ovarian carcinoma who had progressed during or after one platinum-based regimen.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
Topotecan and paclitaxel were evaluated in a randomized, multicenter study of patients with advanced epithelial ovarian carcinoma who had progressed during or after one platinum-based regimen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology – Pubmed
Published: Jul 21, 1997
Access the full text.
Sign up today, get DeepDyve free for 14 days.